Cardax
David M. Watumull has two decades of experience in astaxanthin product development, commercialization, and business management. Mr. Watumull oversees Cardax operations with responsibility for product development and manufacturing, sales and marketing, regulatory compliance, finance, and administration.
This person is not in any offices
Cardax
Cardax (OTCQB: CDXI) is developing proprietary astaxanthin therapies for large unmet medical needs where oxidative stress and inflammation play important causative roles.